ArticleTheranostics2019

Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.

Xiaobin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.